# Taurine in Adolescents With Bipolar Disorder

> **NCT00391001** · PHASE1 · TERMINATED · sponsor: **Cambridge Health Alliance** · enrollment: 4 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Taurine

## Key facts

- **NCT ID:** NCT00391001
- **Lead sponsor:** Cambridge Health Alliance
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-02
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2010-02-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00391001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00391001, "Taurine in Adolescents With Bipolar Disorder". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00391001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*